Discover the course

Pharmacovigilance Documents in the Life Cycle of a Medicinal Product: From Patients to Health Authorities

Development Safety Update Report (DSUR), Risk Management Plan (RMP), Periodic Safety Update Report (PSUR) / Periodic Benefit-Risk Evaluation Report (PBRER), and Addendum to the Clinical Overview 


13-14 Oct 2020





Pharmacovigilance Documents in the Life Cycle of a Medicinal Product: From Patients to Health Authorities

This course gives an overview of the pharmacovigilance activities and the related documents throughout the life cycle of a medicinal product. We will address:

  • benefit-risk analysis
  • signal management
  • data collection process
  • regulatory, format and content requirements. 

While the course is based on the EU requirements, a few relevant insights about the most relevant local requirements will be provided. The participants will learn how to plan and manage documents in the life cycle and how to address selected challenges of document preparation.

    • The life cycle of a medicinal product from the pharmacovigilance perspective 
    • Benefit-risk analysis 
    • Signal management and data collection 
    • Development Safety Update Report (DSUR) 
    • Periodic Safety Update Report (PSUR)/ Periodic Benefit-Risk Evaluation Report (PBRER) 
    • Risk Management Plan (RMP) 
    • Addendum to Clinical Overview (AddCO) 
    • Document assessment 
    • Referrals 
    • Planning, gap analysis and preparation of PV documents. 

    Course Language

    The course will be in English.

    Marco Anelli
    Marco Anelli Head of Medical Affairs and Pharmacovigilance Advisory Practice - PLG (Product Life Group)

    Marco Anelli has been appointed in January 2016 “Head of Pharmacovigilance and Medical Affairs Advisory Services” at PLG. As “Deputy Chief Scientific Officer” of PLG, Marco coordinates all delivery and research projects (internal and on behalf of clients) linked to Big Data, Knowledge Management, Artificial Intelligence and Machine Learning.
    Previously, Marco was R&D Director at Keypharma, an Italy-based ProductLife Group company, where was responsible for the coordination of all clinical and preclinical aspects of projects run internally and on behalf of clients. Drawing on a career in the pharmaceutical industry that spans 25 years, Marco provides expert oversight on a wide range of R&D and Medical Affairs related activities. Marco has participated in and coordinated all stages of drug development – from formulation to Phase I-IV and pharmacovigilance. In addition, Marco is a qualified QPPV and has prepared and overseen more than 200 non-clinical and clinical overviews and summaries. Before joining Keypharma and PLG, Marco was Medical Affairs Director at Eurand. In the last few years, he has extensively worked in the fields of pharmacoeconomics and health technology assessment.
    He has a medical degree from the University of Milan, specializations in Medical Statistics and Clinical Pharmacology from the University of Pavia and an international master’s degree in health economics and pharmacoeconomics from the University of Pompeu Fabra in Barcelona.

    Tiziana von Bruchhausen
    Tiziana von Bruchhausen Senior Pharmacovigilance Writer at Boehringer Ingelheim

    Tiziana von Bruchhausen, PhD specialises in pharmacovigilance writing and has gained over 10 years’ experience while working in various roles for mid-sized and large pharmaceutical companies. She is currently employed as a senior pharmacovigilance writer at Boehringer Ingelheim. Her tasks and responsibilities cover pre- and post-submission activities related to the global strategic planning and the preparation of pharmacovigilance documents with a focus on DSURs, RMPs, PSURs, and health authorities’ assessment reports.
    Tiziana actively promotes the professional role of medical writers in pharmacovigilance through workshops and lectures Europe-wide and has served as a session chair at international conferences. She is an active volunteer at the European Medical Writers Association (EMWA), where she has been chairing since 2017 the Pharmacovigilance Special Interest Group Committee. She was Vice President of EMWA in 2017-2018 and President in 2018-2019.

    Drug Safety and Pharmacovigilance department, Regulatory Affairs department and Quality and Compliance department (e.g. medical writers, pharmacovigilance writers, pharmaco¬vigilance officers, pharmacovigilance managers, QPPVs, safety physicians, managers regulatory affairs and medical evaluators/advisors, document quality and compliance managers).

    Participant experience 

    Basic knowledge of drug development and pharmacovigilance.

    Presentation, hands-on exercises, group and class discussions

    The training course will take place in Copenhagen.

    Upon Arrival
    At your arrival you will find our Staff at the Welcome Desk to greet and make you feel welcome and as comfortable as possible, providing direction and all information about the meeting, seating, refreshments.

    Coffee breaks and lunch will provide a pleasant moment of refreshment. Special care about the food quality, in particular to your dietary needs or preferences, from menus of local products and flavors to vegetarian dishes.

    Limited number of participants to encourage networking and discussion.

    Training Room

    All our training facilities are safe, healthy, comfortable, aesthetically-pleasing, and accessible. They are able to accommodate the specific space and equipment needs of the training program.
    Depending on the seating configuration, the room may accommodate lecture-style instruction or encourage interaction in the form of roundtable discussions. Equipped for audio/visual, Free Wi-Fi to allow everyone to connect with just one click, electric sockets.

    Teaching materials

    All the information necessary for learning during the course is provided. It is recommended to bring your PC to take notes (even directly on the slides provided in PDF format). The environment is important to us and that's why we try to make this meeting an experience of environmental sustainability.

    Fee includes
    Tuition, teaching materials, lunch and coffee breaks, organizational office assistance, attendance certificate. 

    The course will proceed with a minimum number of participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.
    Certificate of attendance

    Early Bird: € 1.670,00* (until 15 September 2020)

    Ordinary: € 1.880,00*

    Freelance - Academy - Public Administration**: € 990,00*

    * for Italian companies: +22% VAT

    ** Early Bird discount not applicable to Freelance - Academy - Public Administration fee

    The fee includes: tuitions, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate.

    Register now

    Course Price

    1880.00 €

    Early Bird

    Tuesday, September 15, 2020

    1670.00 €

    Payments accepted

    • Bank Transfer
    • Credit Card
    • PayPal

    Other Details


    2 days

    Course Type

    Limited number of partecipants

    You will receive

    Certificate of attendance

    At the end of the training, you will be able to

    • Understand the main pharmacovigilance activities in the life cycle of the medicinal product

    • Plan and prepare DSUR, PSUR/PBRER, RMP, and AddCO, exploiting similarities and synergies among the different documents

    • Apply writing skills to the preparation of pharmacovigilance documents

    Participants' Feedbacks

    Number of people contained wich allows interaction

    Exemples from real life situations from the workplace were very useful.

    Practical exercises have been extremely useful

    Professionalism and competence of the trainer

    Excellent points to share and ideas in daily practice to make your own

    Exhaustive, interactive and clear explanations

    Possibility to interact with different actors involved in  tender processes

    You may also be interested in

    Close Menu


    Pharmacovigilance Documents in the Life Cycle of a Medicinal Product: From Patients to Health Authorities

    information request

    Terms & Conditions

    The fee includes: tuition, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate. Early Bird discount not applicable to Freelance – Academy – Public Administration fee.
    The course will proceed with a minimum of 8 participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.
    For further information please contact:  e-mail:  telephone: +39 (0)35.515684

    The fee includes: seat at the conference, copy of presentations of Speakers who allow the distribution, informative literature for the day, networking lunch, coffee break, organisational office assistance, certificate of attendance. For further information please contact:  e-mail:  telephone: +39 (0)35.515684

    Common Terms & Conditions

    Terms of payment
    Payment should be made online (by credit card) or by bank transfer, at the time of registration (only for Italian companies: + 22% VAT) to EasyB s.r.l by bank transfer or by credit card. Bank transfer payable to:

    EasyB S.r.l.
    Via Roma, 20 – 24022 Alzano Lombardo (Bergamo)
    VAT: IT03633040161
    BANCO BPM – Filiale di Carobbio degli Angeli
    IBAN: IT81 F 05034 53960 000000003450

    Confirmation of event admission will be given on receipt of payment. Invoice will be sent following receipt of payment. EasyB reserves the right to refuse late registrations or additional registrations above the maximum accepted number of participants or registrations of roles that are not included in the target of the event.

    Please note that refunds (70% refund of the registration fee) will only be given if cancellation is received at least one week before the event date. Cancellations will only be valid if made in writing. Transfer of registrations (or name changes) are allowed and should be made in writing within 7 days prior to the event. EasyB reserves the right to postpone or cancel an event, to change the location of an event or to alter the advertised speakers for an event. EasyB is not responsible for any loss or damage as a result of substitution, alteration, postponement or cancellation of an event due to causes beyond its control including without limitation, acts of God, natural disasters, sabotage, accident, trade of industrial disputes, terrorism, or hostilities.

    Information collection and use
    In accordance with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016, we inform you that EasyB S.r.l. (with headquarter in Via Roma 20, Alzano Lombardo, Bergamo, Italy, VAT number IT03633040161) will use your personal data voluntarily provided by you only with the consent and in compliance with the principles dictated by the European Regulations on the protection of personal data for sending newsletters, for marketing purposes (sending advertising material, market research and commercial communication) and for communication purposes to third parties (lecturers, scientific board, speakers, conferences’ sponsor), also for marketing goals. You can read the complete information, including your rights and the procedures for the exercise of the same, 
    following this link.